Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Imipenem/pharmacology"'
Autor:
Marta Hernández-García, María García-Castillo, Germán Bou, Emilia Cercenado, Mercedes Delgado-Valverde, Antonio Oliver, Cristina Pitart, Jesús Rodríguez-Lozano, Nuria Tormo, José Melo-Cristino, Margarida F. Pinto, Elsa Gonçalves, Valquíria Alves, Ana Raquel Vieira, Elmano Ramalheira, Luísa Sancho, José Diogo, Rui Ferreira, Hugo Cruz, Catarina Chaves, Joana Duarte, Leonor Pássaro, Jazmín Díaz-Regañón, Rafael Cantón
Imipenem-relebactam is a novel β-lactam-β-lactamase inhibitor combination. We evaluated the in vitro activity of imipenem-relebactam and comparators against Enterobacterales clinical isolates recovered in 8 Spanish and 11 Portuguese intensive care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1423cf93d74f508065092d56192a24
https://hdl.handle.net/10668/20046
https://hdl.handle.net/10668/20046
Autor:
Stefano Leo, Damien Baud, Adrien Nicolas Fischer, Abdessalam Cherkaoui, Patrice Francois, Etienne Ruppé, Jacques Schrenzel, Nadia Gaïa
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases, Vol. 37, No 11 (2018) pp. 2201-2210
The aims of the present study were to characterize the mechanisms of resistance to fluoroquinolones, macrolides, and imipenem in Haemophilus influenzae, to assess the extent of the AcrAB-TolC-mediated resistance, and to define a core genome multilocu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e4b32edd33e02c1ceb36773cfa4b0f
https://pubmed.ncbi.nlm.nih.gov/30145620
https://pubmed.ncbi.nlm.nih.gov/30145620
Autor:
José Campos, Alberto Delgado-Iribarren, JM Saavedra, Luis Martínez-Martínez, Dolores Vega, Jesús Oteo, María Cruz Rodríguez, Silvia García-Cobos, María Pérez-Vázquez, Verónica Bautista, María Velasco
Publikováno v:
International journal of antimicrobial agents, 32(6), 534-537. Elsevier Bedrijfsinformatie b.v.
The molecular epidemiology and the mechanisms of resistance of Escherichia coli isolated from two patients infected by imipenem-resistant strains are reported in this study. From one patient, three closely related consecutive isolates of E. coli were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6353009399f4091eb12032b6486a67
https://hdl.handle.net/11370/b788bef8-95a6-4239-ae9e-efcd8f0bf319
https://hdl.handle.net/11370/b788bef8-95a6-4239-ae9e-efcd8f0bf319
Autor:
Adriana Renzoni, Abdessalam Cherkaoui, Seydina M. Diene, Jacques Schrenzel, Patrice Francois, Gesuele Renzi, Stéphane Emonet
Publikováno v:
Clinical Microbiology and Infection, Vol. 23, No 2 (2017) pp. 118.e9-118.e19
Objective To investigate the potential roles of PBPs, efflux pumps and slow drug influx for imipenem heteroresistance in nontypeable Haemophilus influenzae (NTHi). Methods Fifty-nine NTHi clinical isolates examined in this study were collected at Gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00c4ddede4774941d45698a5058c396
https://doi.org/10.1016/j.cmi.2016.10.009
https://doi.org/10.1016/j.cmi.2016.10.009
Autor:
Belén Aracil, Emilia Cercenado, María Pérez-Vázquez, Noelia Lara, José Campos, Margarita Arroyo, Silvia García-Cobos, Jesús Oteo
Publikováno v:
Journal of Antimicrobial Chemotherapy, 69(1), 111-116. Oxford University Press
OBJECTIVES: The epidemiology of invasive Haemophilus influenzae has changed in recent years. β-Lactamase-negative ampicillin-resistant (BLNAR) invasive isolates have recently been described in Europe but their clinical significance is unclear. Our m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e4f49c0f1e4b9c029b0e206e027405
https://pubmed.ncbi.nlm.nih.gov/23943391
https://pubmed.ncbi.nlm.nih.gov/23943391
Autor:
Pierre Vaudaux, Daniel Pablo Lew, Christian Chuard, Heinz J. Schaad, Francis Waldvogel, Peter Rohner
Publikováno v:
Journal of Antimicrobial Chemotherapy, Vol. 33, No 6 (1994) pp. 1191-1200
The efficacies of imipenem when directed against methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains of Staphylococcus aureus were compared with those of oxacillin and vancomycin in a subcutaneous rat model, using chronically infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f918ad77cd83d47b2601fda53bbbec
https://doi.org/10.1093/jac/33.6.1191
https://doi.org/10.1093/jac/33.6.1191
Autor:
Andres Hagerman, Pierre-Alex Crisinel, Patrick Boiron, Klara M. Posfay-Barbe, Veronica Rodriguez-Nava
Publikováno v:
Journal of Clinical Microbiology
Journal of Clinical Microbiology, American Society for Microbiology, 2011, 49 (3), pp.1185-1187. ⟨10.1128/JCM.02073-10⟩
Journal of Clinical Microbiology, Vol. 49, No 3 (2011) pp. 1185-7
Journal of Clinical Microbiology, American Society for Microbiology, 2011, 49 (3), pp.1185-1187. ⟨10.1128/JCM.02073-10⟩
Journal of Clinical Microbiology, Vol. 49, No 3 (2011) pp. 1185-7
Nocardia spp. can lead to local or disseminated infections, especially in immunocompromised patients. Combination therapy of amikacin and imipenem is commonly used to treat severe nocardial infections. We describe a patient with imipenem-resistant No
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b385068f17d6b87a40c251811f4e5e0e
https://pubmed.ncbi.nlm.nih.gov/21177900
https://pubmed.ncbi.nlm.nih.gov/21177900
Publikováno v:
Acta clinica Croatica
Volume 40
Issue 3
Volume 40
Issue 3
The study was performed to determine the consumption of imipenem and resistance of gram-negative pathogens (Pseudomonas aeruginosa, Acinetobacter sp., Klebsiella sp., Escherichia coli, Proteus mirabilis, Serratia marcescens, Enterobacter sp.) to imip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::8865ac77bbc2a82eef9fb1ba5b0662be
https://hrcak.srce.hr/file/22664
https://hrcak.srce.hr/file/22664
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.